It reduces NR2B overexpression in the acute phase, aligning with studies showing that NR2B antagonists suppress excitability and restores its expression in the chronic phase to support cognitive function, countering the memory impairments associated with low NR2B levels [22, 23, 24, 25, 26]. This evidence concerns the gene GRIN2B and memory impairment.